Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

Claudio MarascaDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]

Angelo RuggieroDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy

Matteo MegnaDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy

https://orcid.org/0000-0003-1803-2046

Maria Carmela AnnunziataDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy

Gabriella FabbrociniDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy

References

Conforti C, Giuffrida R, Dianzani C, et al. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020;e13298.
PubMed Web of Science ®Google Scholar
Bardazzi F, Loi C, Sacchelli L, et al. Biologic therapy for psoriasis during the covid-19 outbreak is not a choice. J Dermatolog Treat. 2020;31:1–2.
PubMed Web of Science ®Google Scholar
Megna M, Ruggiero A, Marasca C, et al. Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears. J Dermatolog Treat. 2020;31:1–2.
PubMed Web of Science ®Google Scholar
Gisondi P, Facheris P, Dapavo P, et al. The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience. Br J Dermatol. 2020.
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date